STZ
54
2
CVS
31
2
XEL
53
-2
MAS
52
-2
FLS
69
-2
WU
28
-4
AAP
29
-3
BIIB
38
-2
A
39
-2
ISRG
68
-3
XRX
52
3
MTCH
48
11
XRAY
47
-2
EL
34
-3
PRU
45
-2
HAS
32
-5
NKE
37
-3
AZO
62
4
SIG
54
2
PVH
60
2
STZ
54
2
CVS
31
2
XEL
53
-2
MAS
52
-2
FLS
69
-2
WU
28
-4
AAP
29
-3
BIIB
38
-2
A
39
-2
ISRG
68
-3
XRX
52
3
MTCH
48
11
XRAY
47
-2
EL
34
-3
PRU
45
-2
HAS
32
-5
NKE
37
-3
AZO
62
4
SIG
54
2
PVH
60
2
Financhill
Back

Swedish Orphan Biovitrum AB 10K Form

Buy
66

SWOBY
Swedish Orphan Biovitrum AB

Last Price:
15.00
Seasonality Move:
0.77%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SWOBY News And Ratings

See the #1 stock for the next 7 days that we like better than SWOBY

SWOBY Financial Statistics

Sales & Book Value

Annual Sales: $2.09B
Cash Flow: $-101.56M
Price / Cash Flow: 31.48
Annual Sales: $5.36
Price / Book: 2.62

Profitability

EPS (TTM): 0.48740
Net Income (TTM): $335.84M
Gross Margin: $1.62B
Return on Equity: 9.88%
Return on Assets: 4.75%

Swedish Orphan Biovitrum AB Earnings Forecast

Key Swedish Orphan Biovitrum AB Financial Ratios

  • The Gross Profit Margin over the past 22 years for SWOBY is 77.42%.
  • The Selling, General & Administrative Expenses for SWOBY have been equal to 45.93% of Gross Profit Margin.
  • The Research & Development expenses have been 12.64% of Revenue.
  • The Interest Expense is 46.12% of Operating Income.
  • The Net Earning history of SWOBY is 10.89% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 11 years.

Swedish Orphan Biovitrum AB Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Biotechnology
Sector: Health Care
Current Symbol: SWOBY
Website: sobi.com

Debt

Debt-to-Equity Ratio: 0.47
Current Ratio: 0.91
Quick Ratio: 0.62

Price-to-Earnings

Trailing P/E Ratio: 40.19
Forward P/E Ratio: 0

SWOBY Technical Analysis vs Fundamental Analysis

Buy
66
Swedish Orphan Biovitrum AB (SWOBY) is a Buy

Is Swedish Orphan Biovitrum AB a Buy or a Sell?